Description
Cranlex Chewable Tablets — Dual-Action Support for Recurrent UTI Management
Cranlex Chewable Tablets combine Cranberry Extract 350 mg with D-Mannose 600 mg in a convenient chewable format aimed at recurrent urinary tract infections. Cranberry Extract is associated with decreasing the number of symptomatic UTIs in patients prone to recurrence, while D-Mannose works by reducing the risk of recurrent UTI and is noted for carrying a lower risk of side effects compared to Nitrofurantoin in these patients. This dual-action combination makes Cranlex Chewable Tablets relevant for uncomplicated UTI, recurrent urinary tract infections and antibiotic-resistant UTI cases, giving franchise partners a genuinely useful non-antibiotic option to offer alongside conventional UTI therapy.
A Chewable Format Backed by Certified Manufacturing
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. Chewable tablets require careful formulation to balance taste, texture and active stability and Cranlex is manufactured under strict quality control to maintain this consistency across every batch. For a PCD pharma franchise company in India, offering a natural, non-antibiotic solution for recurrent UTIs gives field partners a distinctive product to introduce to urologists, gynaecologists and general physicians managing bladder health concerns.
Product Highlights for Franchise Partners
- Composition: Cranberry Extract (25% Proanthocyanidins) 350 mg + D-Mannose 600 mg
- Dosage Form: Chewable Tablets
- Pack Size: 10x1x10 Tablets
- Indications: Uncomplicated UTI, recurrent urinary tract infections, antibiotic-resistant UTI
- Key Benefit: Dual-action support for urinary tract health and bladder wellness
- Suited For: Distributors and medical representatives expanding their urology and women’s health range
Franchise partners looking to add a natural recurrent-UTI support formula to their portfolio can explore this and other formulations through our PCD pharma franchise division, with complete launch support.
Disclaimer: This product should be used as advised by a registered medical practitioner or healthcare professional.
